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Abstract
Objective: To determine whether children and youths with Type 1 diabetes (T1D)
have early alterations of the corneal subbasal nerve plexus detectable with in vivo
confocal microscopy (IVCM) and to investigate the role of longitudinally measured
major risk factors for diabetes complications associated with these alterations.
Methods: One hundred and fifty children and youths with T1D and 51 age-matched
controls were enrolled and underwent IVCM. Corneal nerve fiber length (CNFL), cor-
neal nerve fiber density (CNFD), corneal nerve branch density (CNBD), corneal fiber
total branch density (CTBD), and corneal fiber fractal dimension (CNFrD) were mea-
sured. Risk factors for diabetes complications (blood pressure, BMI, HbA1c, lipopro-
teins, urinary albumin-creatinine ratio) were recorded at IVCM and longitudinally
since T1D onset. Unpaired t-test was used to compare variables between the groups.
Multiple regression models were calculated using IVCM parameters as dependent
variables and risk factors as independent variables.
Results: All IVCM parameters, except CTBD, were significantly lower in the T1D
patients. Glycometabolic control (HbA1c, visit-to-visit HbA1c variability, and mean
HbA1c), and blood pressure were inversely correlated with IVCM parameters. Multiple
regression showed that part of the variability in CNFL, CNFD, CTBD, and CNFraD was
explained by HbA1c, blood pressure percentiles and age at IVCM examination, indepen-
dent of diabetes duration, BMI percentile and LDL cholesterol. Comparable results were
obtained using the mean value of risk factors measured longitudinally since T1D onset.
Conclusions: Early signs of corneal nerve degeneration were found in children and
youths with T1D. Glycometabolic control and blood pressure were the major risk fac-
tors for these alterations.
Abbreviations: ACR, albumin-creatinine ratio; BMI, body-mass index; CNBD, corneal nerve branch density; CNFD, corneal nerve fiber density; CNFL, corneal nerve fiber length; CNFrD, corneal
nerve fiber fractal dimension; CTBD, corneal nerve fiber total branch density; DBP, diastolic blood pressure; HDL, high density lipoprotein; ISPAD, International Society for Pediatric and
Adolescent Diabetes; IVCM, in vivo confocal microscopy; LDL, low density lipoprotein; SBP, systolic blood pressure; T1D, Type 1 diabetes; TG, triglycerides.
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1 | INTRODUCTION
Diabetic retinopathy and neuropathy are two major microvascular compli-
cations of Type 1 diabetes (T1D). They have an insidious onset, with overt
symptoms manifesting only when damage to the retina and peripheral
nerves is at an advanced stage.1,2 There is mounting evidences that impair-
ment of microvascular components is preceded by very early neurodegen-
erative alterations primarily involving small nerve fibers.3,4 In vivo confocal
microscopy (IVCM) of the corneal subbasal nerve plexus has substantially
corroborated these findings in adult patients with diabetes.5,6 IVCM is a
safe and non-invasive imaging technique for the direct visualization of this
corneal layer, which is predominantly composed of small and unmyelinated
C-fibers.7 Corneal nerve length and density parameters are altered in T1D
patients with neuropathy compared to those without neuropathy, and
there is a significant correlation between these parameters and the results
of conventional tests8,9 and intra-epidermal nerve fiber density measured
with skin biopsy.10 Early corneal neurodegenerative changes in T1D adults
has been associated with worse glycemic control and higher blood pres-
sure, two recognized major risk factors for diabetes complications.11 More-
over, longitudinal studies have demonstrated that improvement of these
risk factors, as well as combined kidney and pancreas transplantation, can
regenerate corneal nerve fibers12,13 .
The acceptability, reliability, and reproducibility of IVCM in
healthy and T1D children and adolescents have been demon-
strated.14,15 However, the few studies that have been conducted in
young T1D patients have had modest sample size and inconsistent
results for the possible predisposing role of the main risk factors for
diabetes complications in causing corneal nerve fiber damage.16–18
The early detection of corneal nerve fiber damage in young
patients with T1D is particularly valuable, given the limitations of con-
ventional diagnostic tools for the diagnosis of early signs of diabetic
neuropathy in childhood and adolescence and the importance of
prompt intervention to prevent or delay its progression in child-
hood.2,19 The primary aim of this study was to determine whether
children and youths with T1D have early alterations of the corneal
subbasal plexus compared to age-matched healthy controls. The sec-
ondary aim was to investigate the role of longitudinally measured risk
factors for diabetes complications in causing these alterations in a
large cohort of children and youths with T1D.
2 | METHODS
2.1 | Study population
Children, adolescents, and young adults with T1D and a history of
diabetes of at least 2 years were recruited from among patients
attending the Regional Center for Pediatric Diabetes of the Uni-
versity Hospital, Verona, between June 2018 and August 2019.
Exclusion criteria were: diagnosis of diabetic retinopathy based on
mydriatic fundoscopy examination and/or diagnosis of diabetic
neuropathy after evaluation of neurologic symptoms based on the
diabetic neuropathy symptom score and standard clinical tests
(assessment of ankle tendon reflexes and temperature, pinprick
and vibration perceptions) with calculation of the neuropathy dis-
ability score,20 21 as recommended by current International Soci-
ety for Pediatric and Adolescent Diabetes (ISPAD) guidelines2;
diagnosis of other forms of neuropathies, celiac disease with low
compliance to gluten-free diet, not-euthyroid Hashimoto's thyroid-
itis, and other systemic chronic diseases other than T1D. Ophthal-
mological exclusion criteria were: history of corneal abnormality,
ocular trauma or surgery, dry eye disease, and/or contact
lens wear.
A healthy, age- and sex-matched control group was enrolled from
among outpatient children and youths attending the Eye Clinic,
Department of Neurosciences, Biomedicine and Movement Sciences,
Verona University, for minor ocular symptoms or general screening
ophthalmic examination but with no history of relevant ocular and
systemic disease (including diabetes).
All procedures were performed in accordance with the tenets of
the Declaration of Helsinki. The study protocol was approved by
the Ethics Committee of Verona; participants and their parents/legal
guardians provided written, informed consent after explanation of the
nature of the study.
2.2 | Clinical and biochemical data collection
At study enrolment, all participants underwent physical examination
for the collection of anthropometric (height, weight, waist circumfer-
ence, body-mass index [BMI] and BMI percentile) and blood pressure
measurement (systolic blood pressure [SBP], diastolic blood pressure
[DBP], and percentile by sex, age, and height).22 In patients with T1D,
urinary and venous blood samples were collected for analysis of the
urinary albumin-creatinine ratio (ACR), HbA1c, and lipid profile (tri-
glycerides [TG], total cholesterol, high density lipoprotein [HDL] cho-
lesterol, low density lipoprotein [LDL] cholesterol). Age at onset,
duration of T1D, type of insulin therapy, and daily insulin dosage were
recorded. In addition, these clinical and biochemical data annually col-
lected starting from T1D onset were retrospectively retrieved and the
mean of all the values recorded was calculated for each parameter.
HbA1c values were also used for calculation of visit-to-visit HbA1c
variability (HbA1c SD) as an index of long-term glycometabolic
variability.
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2.3 | Ophthalmologic examination and in vivo
confocal microscopy
All participants underwent complete bilateral ophthalmologic exami-
nation, including slit lamp examination of the anterior segment and
mydriatic fundoscopy. The corneal subbasal nerve plexus was
assessed by IVCM (Heidelberg Retinal Tomography III with Rostock
Cornea Module, Heidelberg Engineering, Heidelberg, Germany) by the
same expert operator (TC) according to published standard protocols
for examination, image acquisition, and analysis.23,24 The subject's
eyes were anesthetized with a drop of topical lidocaine hydrocloride
40 mg/ml (A23lfa Intes Pharmaceuticals, Casoria, Italy) and a drop of
ophthalmic tear gel (Tear Gel carbomer 0.3%, Thea Pharmaceuticals,
Clermont-Ferrand, France) was used as coupling medium between the
microscope objective lens and the corneal surface. Scans of the cen-
tral and paracentral cornea were acquired using a sequence module
for recording one image per second. To achieve the best possible
quality of nerve images, the examiner manually focused the subbasal
nerves while scanning and adjusting the axial depth dial (image resolu-
tion 384  384 pixels with a 400 μm2 field of view lens). The total
duration of the IVCM examination was about 2 min per eye.
After the examination, the examiner chose six images per eye for
each participant, selecting from among high-contrast images without
artefacts. The images were then processed using ACCMetrics Image
Analysis Software v 2.0,25 to quantify five corneal nerve parameters
for each eye: (1) corneal nerve fiber length (CNFL)-the total length of
all nerve fibers and branches (mm/mm2) within the scanned area;
(2) corneal nerve fiber density (CNFD)-the total number of major
nerves per square millimeter of corneal tissue (n/mm2); (3) corneal
nerve branch density (CNBD)-the number of branches emanating
from major nerve trunks per square millimeter of corneal tissue
(n/mm2); (4) corneal nerve fiber total branch density (CTBD)-the total
number of branch points/mm2; and (5) corneal nerve fiber fractal
dimension (CNFrD)-a dimensionless measure of corneal nerve com-
plexity. There were no significant differences between measurements
of the left and the right eye; the average of each corneal nerve param-
eter from both eyes was entered in the data analysis, as previously
described.15,23
2.4 | Statistical analysis
The normal distribution of all variables was assessed by the
Kolmogorov–Smirnov test. Unless otherwise specified, the data
are presented as the mean and SD in brackets. The data between
the T1D patients and the healthy controls were compared using
unpaired Student's t-test for continuous variables and chi-square
test for categorical variables. The relationships between the vari-
ables related to the main clinical and biochemical risk factors for
diabetes complications and IVCM parameters were assessed
using Pearson's correlation coefficients. On the basis of the
results of correlation analysis, outlining how variables are inter-
related, and of the known biological plausibility regarding the
possible causal association between biological factors and early
neurodegenerative changes, multiple regression analysis was per-
formed using IVCM parameters as dependent variables and clini-
cal and biochemical risk factors for diabetes complications as
independent variables. All tests were two-sided; a probability
value (p) < 0.05 was accepted as statistically significant. Statisti-
cal analysis was performed using SPSS (IBM Corp. Released
2010. IBM SPSS Statistics for Windows, version 20. Armonk, NY,
USA: IBM Corp.).
3 | RESULTS
A total of 150 children, adolescents, and young adults with T1D
(age range, 10–22 years) were recruited. Table 1 presents the clin-
ical and demographic characteristics of the T1D patients and the
51 age- and sex-matched controls. There was no difference in age,
sex, pubertal status distribution, anthropometric and blood pres-
sure measurements between patients and controls. The scores for
symptoms and/or signs of diabetic neuropathy and neuropathy
disability were 0 in the T1D patients. Ophthalmologic findings
were within the normal range for all participants. Mydiatric
fundoscopy detected no signs of diabetic retinopathy in the T1D
patients.
Figure 1 presents the IVCM parameters. There was no significant
difference in CTBD between the T1D patients and the controls (40.63
[16.59] vs. 43.67 [15.24] n/mm2; p = 0.254). All other parameters
were significantly lower in the T1D patients: CNFL (14.51 [2.87]
vs. 15.70 [2.26] mm/mm2; p = 0.005); CNFD (23.77 [5.43] vs. 27.93
[4.79] n/mm2; p < 0.001); CNBD (26.75 [12.34] vs. 29.83 [10.61]
n/mm2; p = 0.013); CNFraD (1.481 [0.026] vs. 1.492 [0.019];
p = 0.002).
Correlation analysis did not show significant correlations
between IVCM parameters and age, diabetes duration, sex, pubertal
status, BMI, lipid profile, and ACR measured at study enrolment and
since the onset of T1D. A significant correlation was found between
age at onset of diabetes and CNBD, with no comparable results for
the other IVCM parameters. The SBP percentile measured at IVCM
examination was inversely correlated with all IVCM parameters. In
addition, the mean SBP percentile was significantly correlated with
CNFraD. The DBP was not significantly associated with IVCM
parameters. A significant inverse correlation was found between
HbA1c measured at IVCM examination and all IVCM parameters.
Comparable results were obtained for correlation analysis of visit-
to-visit HbA1c variability (HbA1c SD) and mean HbA1c. No signifi-
cant correlations were found between IVCM parameters and insulin
requirements.
Table 2 and Supplementary Table 3 present the results of
multiple regression analysis of clinical and biochemical risk fac-
tors for diabetes complications measured at study enrolment as
independent variables. The inter-individual variability of CNFL
was explained by HbA1c, BP percentile, and age (R2 = 0.144;
p = 0.03), independent of diabetes duration, BMI percentile, and
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lipid profile (LDL cholesterol). In detail, CNFL increased by 0.263
for each year of age and decreased by 0.744 for each 1% of
HbA1c and by 0.019 for each percentile unit of systolic blood
pressure. Comparable results were obtained using the same inde-
pendent variables for CNFD (R2 = 0.133; p = 0.002), CTBD
(R2 = 0.164; p < 0.001), and CNFraD (R2 = 0.126; p = 0.001),
TABLE 1 Clinical and demographic
characteristics of T1D patients and
healthy controls
Characteristic T1D patients (n = 150) Controls (n = 51) p-value
Gender (m/f) 77/73 25/26 0.77
Puberty (pubertal/post-pubertal) 34/116 10/41 0.64
Age (years) 16.6 (4.0) 16.3 (2.9) 0.64
BMI [kg/m2] 22.0 (3.8) 21.7 (2.7) 0.62
BMI [kg x (m2)] percentile 61.2 (27.4) 64.8 (28.2) 0.43
SBP (percentile) 38.1 (25.2) 39.3 (15.8) 0.83
DBP (percentile) 57.0 (22.4) 56.2 (20.5) 0.78
Age at onset (years) 7.5 (3.6) NA —
Diabetes duration (years) 8.7 (4.2) NA —
HbA1c (%; mmol/mol) 8.07 (0.71); 65 (5.7) NA —
LDL cholesterol (mmol/L; mg/dl) 1.98 (0.63); 76.6 (24.5) NA —
HDL cholesterol (mmol/L; mg/dl) 1.53 (0.34); 59.6 (13.2) NA —
Triglycerides (mmol/L; mg/dl) 2.03 (0.76); 67.5 (30.3) NA —
ACR (mg/mmol) 1.85 (1.62) NA —
Abbreviations: ACR, albumin/creatinine ratio; BMI, body-mass index; DBP, systolic blood pressure; HDL,
high density lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure.
F IGURE 1 Box and whiskers plot of corneal nerve fiber length (CNFL) (A), corneal nerve fiber density (CNFD) (B), corneal nerve branch
density (CNBD) (C), corneal nerve fiber total branch density (CTBD) (D), and corneal nerve fiber fractal dimension (CNFraD) (E) values in Type
1 diabetes (T1D) patients and healthy controls
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whereas for CNBD, diabetes duration, in addition to HbA1c, BP
percentile, and age at IVCM examination, contributed to explain
the inter-individual variability of this IVCM parameter
(R2 = 0.184; p < 0.001). Multiple regression analysis of clinical
and biochemical risk factors for diabetes complications expressed
as the mean of the values recorded since T1D onset showed com-
parable results with visit-to-visit HbA1c variability (HbA1c SD),
mean BP percentiles, and age at IVCM examination significantly
contributed to explain the inter-individual variability of CNFL and
CNFrAD parameters (CNFL R2 = 0.064, p = 0.046; CNFraD
R2 = 0.071, p = 0.025) (Supplemental Table 4).
4 | DISCUSSION
The main finding of this study is the evidence for significant alter-
ations in corneal nerve fiber morphology measured on corneal
subbasal nerve plexus images in the T1D patients compared to the
healthy controls. Also, we noted a significant association between
these parameters and glycometabolic control and blood pressure, two
major risk factors for the development of diabetes complications.
Previous studies in T1D adult patients have demonstrated the
diagnostic validity of IVCM for the detection of early alterations in
corneal nerve fibers and the diagnosis of diabetic neuropathy at its
earliest stages.6 To date, this ophthalmologic approach has seldom
been used in children and youths with T1D, although some studies
have demonstrated that it is acceptable, feasible, reliable, and repro-
ducible in this patient subpopulation.14,15 The few studies that have
been conducted in young T1D patients have produced inconsistent
results: Sellers et al. found no significant difference between healthy
controls and children with T1D,14 whereas Gotze et al. reported a
reduction only in CNFL with no significant alterations in other param-
eters.18 A study by Szalai et al. reported significantly lower values of
corneal nerve fiber length, fiber density, and branch density.17 These
studies had a modest sample size, with a low statistical power for
detecting differences between T1D patients and healthy controls. Dif-
ferently, our study presents results obtained in a large cohort of T1D
children and adolescents and demonstrates a consistent reduction in
fiber length and density parameters, with substantial evidence that
early alterations of small corneal nerve fibers are detectable starting
in children and youths with T1D. The depletion in the subbasal nerve
plexus revealed in our study is documented also by the reduction in
CNFrD, which is a recently defined parameter that measures corneal
nerve structure complexity.26
These results are in line with evidence that the pathogenesis of
diabetic neuropathy is characterized by early involvement of small
and unmyelinated nerve fibers, followed by progressive and length-
dependent neurodegeneration.3 Since the damage is not detectable
on conventional clinical and neurophysiological examinations, the
identification and validation of new markers of small fiber neuropathy
TABLE 2 Multiple regression analysis of clinical and biochemical parameters for the risk factors for diabetes complications measured at IVCM
evaluation
Dependent variable Variables in the model B 95% CI p value
CNFL (R2 = 0.144, p = 0.03) Age 0.263 0.28 – 0.465 0.011
Diabetes duration 0.111 0.250 – 0.028 0.116
HbA1c 0.744 1.430 to 0.057 0.034
BMI percentilea 0.015 0.034 – 0.005 0.144
SBP percentilea 0.019 0.038 – 0.001 0.043
LDL cholesterola 0.010 0.011 – 0.030 0.371
CNFD (R2 = 0.133, p = 0.002) Age 0.566 0.160 – 0.972 0.007
Diabetes duration 0.314 0.592 to 0.037 0.077
HbA1c 1.521 2.90 to 0.142 0.031
BMI percentilea 0.039 0.075 – 0.003 0.077
SBP percentilea 0.33 0.78 to 0.001 0.045
LDL cholesterola 0.002 0.044 – 0.044 0.926
CNBD (R2 = 0.184, p < 0.001) Age 1.132 0.336 – 1.928 0.006
Diabetes duration 0.703 1.244 to 0.160 0.010
HbA1c 3.814 6.477 to 1.150 0.005
BMI percentilea 0.055 0.131 – 0.020 0.150
SBP percentilea 0.099 0.173 to 0.024 0.018
LDL cholesterola 0.029 0.054 – 0.111 0.492
Note: Data about CNFL, CNFD and CNBD are presented.
Abbreviations: BMI, body-mass index; CNBD, corneal nerve branch density; CNFD, corneal nerve fiber density; CNFL, corneal nerve fiber length; LDL, low
density lipoprotein; SBP, systolic blood pressure.
aVariables measured at the time of IVCM examination.
784 COZZINI ET AL.
is particularly important for early diagnosis and prompt therapeutic
intervention.5 In this scenario, IVCM is a valuable non-invasive tech-
nique in clinical practice and for the study of pathogenic mechanisms
underlying neurodegeneration in diabetes.
Analysis of the association between IVCM parameters and risk
factors for T1D complications, longitudinally assessed starting at T1D
onset, showed that glycometabolic control and blood pressure are
major factors for early alteration of corneal nerves. In detail, HbA1c,
measured at IVCM examination and since diabetes onset, was consis-
tently and inversely associated with all IVCM parameters. This obser-
vation is shared by previous studies on the importance of long-term
glycometabolic control for the prevention of diabetic neuropathy27
and, more specifically, alterations of the corneal subbasal plexus.28–30
Moreover, in our cohort of young T1D patients, also visit-to-
visit HbA1c variability (HbA1c SD), an index of long-term
glycometabolic variability, was significantly associated with IVCM
parameters and significantly contributed to predict alterations, as
demonstrated by multiple regression analysis. This novel finding fur-
ther supports evidence for the independent predictive role of
HbA1c variability in the development of microvascular complica-
tions in adolescents with T1D.31 We found a negative association
between IVCM parameters and blood pressure, systolic values in
particular, as reported by a study on the role of long-term exposure
to this risk factor.30
In this cohort of patients with T1D, age and diabetes duration,
two other relevant but unmodifiable risk factors, emerged as signifi-
cant predictors of IVCM parameters: age significantly contributed to
an increase in IVCM parameters, whereas diabetes duration was
negatively associated. These results are not comparable with those
from previous studies of cohorts with a similar age range; longitudi-
nal studies on the role of age and diabetes duration in T1D and
healthy controls are desirable. Based on our data, we may speculate
that diabetes with an early onset during childhood affects corneal
innervation.
This study has some limitations: (1) despite the relatively small
sample size of healthy controls, post-hoc power analysis showed that
the number of T1D patients and healthy controls allowed to detect
possible differences in IVCM parameters with a statistical power of at
least 80% (α error probability 0.05, estimated effect size for CNFL
0.460 with a statistical power of 88%); (2) the sample had European
ancestry, so the results cannot necessarily be extended to children
and adolescents with other ethnic backgrounds.
Numbering among the strengths of the study are: (1) applica-
tion of IVCM with imaging collection and selection performed by
the same expert operator according to standard protocols and
simultaneous analysis of several IVCM parameters; (2) the rela-
tively large sample of young patients with T1D; (3) the complete-
ness of clinical and biochemical risk factors for diabetes
complications assessed at IVCM examination and longitudinally,
starting from T1D onset and including indices of long-term
glycometabolic control and variability.
In conclusion, IVCM proved useful in detecting early markers of
neurodegeneration of the corneal subbasal nerve plexus in children
and youths with T1D. The major risk factors are glycometabolic con-
trol and blood pressure, underlining the importance of maintaining
good metabolic control starting in childhood. Longitudinal analysis of
this cohort will document the evolution of nerve parameters in T1D
patients and confirm the role of the risk factors associated with diabe-
tes microvascular complications.
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